PATENT CLAIM ANALYSIS

Application Number: 15895279
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "207000"]

Abstract:
Pharmaceutical compositions are provided in unit dosage forms comprising ceftolozane and tazobactam in separate unit dosage form containers, ceftolozane prepared in the absence of tazobactam, tazobactam prepared in the absence of ceftolozane, and/or compositions where ceftolozane and tazobactam are first combined within a unit dosage form container.

Claim (Index 2):
The unit dosage form of  claim 1 , comprising a single container enclosing a total of 1,000 mg of ceftolozane active present as ceftolozane sulfate.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.82143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15071530', '14214221', '14285185', '15844961', '14856075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7897379890661427
- 35 USC 102 Novelty (BERT): 0.6343977230015816
- Combined Prediction Score: 0.7742039624596866
- Mean Citation Score: 540.2332100000001
- Max Citation Score: 644.7732
- Similarity Product: 529.9176164020299

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test